Literature DB >> 29244621

On Mourning and Recovery: Integrating Stages of Grief and Change Toward a Neuroscience-Based Model of Attachment Adaptation in Addiction Treatment.

R Andrew Chambers1, Sue C Wallingford2.   

Abstract

Interpersonal attachment and drug addiction share many attributes across their behavioral and neurobiological domains. Understanding the overlapping brain circuitry of attachment formation and addiction illuminates a deeper understanding of the pathogenesis of trauma-related mental illnesses and comorbid substance use disorders, and the extent to which ending an addiction is complicated by being a sort of mourning process. Attention to the process of addiction recovery-as a form of grieving-in which Kubler-Ross's stages of grief and Prochaska's stages of change are ultimately describing complementary viewpoints on a general process of neural network and attachment remodeling, could lead to more effective and integrative psychotherapy and medication strategies.

Entities:  

Keywords:  addiction; attachment; grief; hippocampus; motivation; nucleus accumbens; prefrontal cortex; recovery; stages of change

Mesh:

Year:  2017        PMID: 29244621      PMCID: PMC6383361          DOI: 10.1521/pdps.2017.45.4.451

Source DB:  PubMed          Journal:  Psychodyn Psychiatry        ISSN: 2162-2590


  3 in total

1.  Prevalence and predictors of recreational drug use among medical and nursing students in Cameroon: a cross sectional analysis.

Authors:  Clarence M Mbanga; Derrick T Efie; Desmond Aroke; Tsi Njim
Journal:  BMC Res Notes       Date:  2018-07-28

2.  Teaching Residents to Treat Substance Use Disorders: Overcoming 10 Common Patient-Perceived Barriers to Outpatient Treatment Engagement.

Authors:  Stephanie M Davidson; Hilary S Connery; Shelly F Greenfield; Kevin P Hill
Journal:  Acad Psychiatry       Date:  2021-01-13

Review 3.  What can we learn from PWS and SNORD116 genes about the pathophysiology of addictive disorders?

Authors:  Juliette Salles; Emmanuelle Lacassagne; Sanaa Eddiry; Nicolas Franchitto; Jean-Pierre Salles; Maithé Tauber
Journal:  Mol Psychiatry       Date:  2020-10-20       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.